Anu Mahajan, Arti Muley, Shailaja Kale, Sumit Sharma
{"title":"Effect of a lacto-vegetarian diet combined with 14-hour time-restricted eating on metabolic outcomes in women with Type 2 diabetes: a 24-week randomized controlled trial.","authors":"Anu Mahajan, Arti Muley, Shailaja Kale, Sumit Sharma","doi":"10.1038/s41387-026-00462-6","DOIUrl":"10.1038/s41387-026-00462-6","url":null,"abstract":"<p><strong>Background: </strong>Women with type 2 diabetes mellitus (T2DM) often require interventions that are culturally acceptable, practical, sustainable, and can be easily fit into their daily routine to manage their blood sugar levels. Although plant-based dietary patterns and time-restricted fasting have demonstrated metabolic benefits, limited evidence exists on their combined effects in Indian women with T2DM.</p><p><strong>Objective: </strong>This trial evaluated whether a lactovegetarian diet combined with 14-hour time-restricted eating improves glycemic and cardiometabolic outcomes compared with usual diabetes care.</p><p><strong>Methodology: </strong>96 women (25-60 years) with T2DM were enrolled in a 24-week, multicenter, randomized, open-label parallel-arm trial; 90 completed the study. The participants were divided into two groups: an intervention group following a structured lacto-vegetarian diet combined with 14-hour fasting, and control group receiving usual diabetes care. The diet contained 15-20% protein, 20-25% fat, and improved carbohydrate quality (50-55% from whole grains/high-fiber foods). Biochemical estimations and anthropometric measurements were taken at baseline and 24 weeks. The study employed an intention-to-treat analysis protocol, and the perceived benefits and safety of the intervention were reported.</p><p><strong>Results: </strong>At 24 weeks, baseline-adjusted between-group comparisons showed significantly greater improvements in the intervention group compared with usual diabetes care. The intervention group had lower adjusted values for body weight, BMI, glycemic, and lipid profiles. The adjusted mean HbA1c was 6.53% in the intervention group compared with 7.65% in the control group, with an adjusted mean difference of -1.12% (95% CI: -1.35 to -0.89; p < 0.001). HOMA-IR was also significantly lower in the intervention group, with an adjusted mean difference of -1.84 (95% CI: -2.27 to -1.41; p < 0.001). Adverse events were mild and transient, while most participants reported improved energy, mood, weight loss, and overall health.</p><p><strong>Conclusion: </strong>A culturally adaptable lacto-vegetarian diet combined with a 14-hour time-restricted fasting regimen safely improves metabolic control and insulin sensitivity in women with Type 2 Diabetes, offering a practical, women-centric strategy that may be implementable within structured clinical nutrition services, although its staffing requirements, cost, and scalability require further evaluation.</p><p><strong>Trial registration: </strong>CTRI/2024/09/073262, Ethical Approval by Institutional Committee: SIU/IEC/781A.</p>","PeriodicalId":19339,"journal":{"name":"Nutrition & Diabetes","volume":"16 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13754792/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Mesenchymal stem cells protect against diabetic nephropathy through gut microbiota-butyrate-mediated inhibition of neutrophil extracellular traps.","authors":"Jinsha Ma, Xingna Liao, Wenchao Wang, Yixiao Quan, Prawesh Acharya, Yihua Bai","doi":"10.1038/s41387-026-00460-8","DOIUrl":"10.1038/s41387-026-00460-8","url":null,"abstract":"<p><strong>Background: </strong>Mesenchymal stem cells (MSCs) have demonstrated therapeutic potential in diabetic nephropathy (DN), yet the underlying mechanisms remain incompletely understood, limiting strategies to enhance their efficacy. This study aimed to elucidate whether MSCs exert renoprotective effects by modulating the gut microbiota and its metabolite short-chain fatty acids (SCFAs).</p><p><strong>Methods: </strong>DN was induced in rats via a high-fat diet (HFD) combined with streptozotocin (STZ) injection. MSCs were administered via tail vein infusion. Therapeutic efficacy was evaluated by renal function parameters, urine biochemistry, and renal histopathology. Neutrophil extracellular trap (NET) formation was assessed using immunofluorescence staining and ELISA. Alterations in gut microbial composition and SCFA profiles were analyzed through 16S rRNA gene sequencing and targeted metabolomics, respectively. The causal role of the gut microbiota was validated using fecal microbiota transplantation (FMT).</p><p><strong>Results: </strong>Administration of MSCs, as well as FMT from MSC-treated donors, significantly ameliorated renal injury and suppressed NET formation in DN rats. Notably, pharmacological induction of NETs abolished the protective effects conferred by MSC-FMT. 16S rRNA sequencing revealed that MSC intervention enriched beneficial bacterial populations, particularly within the family Muribaculaceae. Targeted metabolomic analysis identified a significant elevation of butyrate among fecal SCFAs in MSC-treated rats. Furthermore, exogenous butyrate supplementation recapitulated the inhibitory effects on NET formation and attenuated DN progression.</p><p><strong>Conclusion: </strong>MSC therapy alleviates diabetic nephropathy via a gut-kidney axis mechanism, driven by the enrichment of butyrate-producing microbiota and the subsequent inhibition of neutrophil extracellular trap formation.</p>","PeriodicalId":19339,"journal":{"name":"Nutrition & Diabetes","volume":"16 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13754803/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effectiveness of bitter almond (Amygdalus communis L. var. Amara) gum as a prebiotic on glycemic indices, oxidative stress, and antioxidant biomarkers in women with type 2 diabetes mellitus: a randomized, placebo-controlled trial.","authors":"Zahra Rafiei, Neda Lotfi Yagin, Parvin Dehghan, Soghra Aliasgharzadeh, Mohammad Asghari-Jafarabadi","doi":"10.1038/s41387-026-00458-2","DOIUrl":"10.1038/s41387-026-00458-2","url":null,"abstract":"<p><strong>Background: </strong>Type 2 diabetes mellitus (T2DM) is marked by hyperglycemia, oxidative stress, and systemic inflammation. Prebiotics, such as bitter almond gum (Amygdalus communis L. var. amara), have the potential to influence gut microbiota and metabolic parameters, suggesting their role as dietary interventions for enhancing glycemic control in the management of T2DM. This study evaluated the effects of bitter almond gum on glycemic indices, oxidative stress, and oxidant biomarkers in individuals with T2DM.</p><p><strong>Methods: </strong>This randomized, triple-blinded, placebo-controlled, clinical trial included 44 women with T2DM. They were assigned to either the intervention (n = 22) or control (n = 22) groups receiving 5 g per day of bitter almond gum or maltodextrin, respectively, for a duration of 8 weeks. Various outcomes, including glycemic indices, lipopolysaccharide (LPS) levels, oxidative stress markers, and antioxidant biomarkers, were measured at baseline and again after 8 weeks.</p><p><strong>Results: </strong>Bitter almond gum supplementation significantly reduced insulin levels (-1.23 mg/dL; 95% CI, [-2.40, -0.03]), LPS ( - 6.32 mg/dL; 95% CI, [-9.51, -3.09]), pentosidine (-38.02 mg/dL; 95% CI, [-55.18, -20.71]), and oxidative stress index (OSI) (-5.59 mg/dL; 95% CI, [-10.81, -0.30]), and increased McAuley_index (0.20 mg/dL; 95% CI, [0.14, 0.32]), total antioxidant capacity (TAC) (0.18 mg/dL; 95% CI, [0.07, 0.26]), superoxide dismutase (SOD) (180.20 mg/dL; 95% CI, [65.27, 295.14]), and glutathione peroxidase (GSH-Px) (2.21 mg/dL; 95% CI, [0.78, 3.62]) compared with the placebo group (P < 0.05, ANCOVA adjusted for baseline and confounding factors).</p><p><strong>Conclusion: </strong>Bitter almond gum supplementation for 8 weeks led to improvements in glycemic control, a reduction in oxidative stress, and an enhancement of antioxidant defenses in women with T2DM. These findings indicate its potential as a complementary functional food for managing diabetes.</p>","PeriodicalId":19339,"journal":{"name":"Nutrition & Diabetes","volume":"16 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13752295/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149387342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Elmira Karimi, Barbara Brayner, Michelle A Keske, Lewan Parker, Kimberley L Way, D Lee Hamilton, Chris McGlory, Gunveen Kaur
{"title":"Are polyunsaturated fatty acids beneficial for skeletal muscle microvascular outcomes? A systematic review of animal and human studies.","authors":"Elmira Karimi, Barbara Brayner, Michelle A Keske, Lewan Parker, Kimberley L Way, D Lee Hamilton, Chris McGlory, Gunveen Kaur","doi":"10.1038/s41387-026-00461-7","DOIUrl":"10.1038/s41387-026-00461-7","url":null,"abstract":"<p><p>Diets high in fat, specifically saturated fatty acids, can reduce muscle capillary density and blunt insulin-induced muscle microvascular blood flow (MBF), limiting nutrient delivery to the myocytes, increasing metabolic and vascular disease risk. However, effects of polyunsaturated fatty acids (PUFA) on these outcomes remain unclear. This systematic review aimed to summarize current evidence on the effects of PUFA on muscle capillary density and MBF. A systematic search of Medline Complete, PubMed, Embase, and the Cochrane Library identified studies examining PUFA interventions and microvascular outcomes. The outcomes included capillary density, capillary-to-fiber ratio, and peripheral, arteriolar, or microvascular perfusion in skeletal muscle. Of 1705 records screened, 12 studies met the inclusion criteria (9 animal and 3 human studies). In animal models, n-3 PUFA supplementation, primarily as fish oil, improved muscle capillary density and prevented impairments in MBF induced by ischemia or endotoxin infusion. These effects were potentially mediated through increased vascular endothelial growth factor, nitric oxide, and prostacyclin production. In contrast, n-6 PUFA showed no consistent benefits. Human studies in this area are very limited. Overall, animal studies suggest n-3 PUFA may enhance skeletal muscle microvascular function, but well-designed human studies are needed to confirm these findings.</p>","PeriodicalId":19339,"journal":{"name":"Nutrition & Diabetes","volume":"16 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13748533/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149379911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zhu Jun, Zhou Jianmin, Wang Jiawen, Dong Wenyun, Cai Jialin, Mohammad Hassan Sohouli, Jiang Shenglu
{"title":"Impact of carotenoids on body composition and adipokine hormones: a systematic review and meta-analysis of randomized controlled trials.","authors":"Zhu Jun, Zhou Jianmin, Wang Jiawen, Dong Wenyun, Cai Jialin, Mohammad Hassan Sohouli, Jiang Shenglu","doi":"10.1038/s41387-026-00459-1","DOIUrl":"10.1038/s41387-026-00459-1","url":null,"abstract":"<p><p>Carotenoids, a class of antioxidant phytochemicals, have been proposed to influence adiposity and metabolic regulation through modulation of oxidative stress, inflammation, and adipokine secretion. However, clinical evidence remains inconsistent. This systematic review and meta-analysis aimed to quantitatively evaluate the effects of carotenoid supplementation on anthropometric and adipokine parameters, including body weight, body mass index (BMI), waist circumference (WC), hip circumference (HC), body fat percentage, fat-free mass (FFM), leptin, and adiponectin. Following PRISMA 2020 guidelines, randomized controlled trials (RCTs) published up to October 2025 were identified through PubMed, Scopus, Embase, and Web of Science. Weighted mean differences (WMDs) with 95% confidence intervals (CIs) were calculated using random-effects models. Heterogeneity and publication bias were assessed via I² statistics and Egger's test, respectively. Twenty-seven RCTs were included. Carotenoid supplementation significantly reduced body weight (WMD: -1.00 kg; 95% CI: -1.87 to -0.13) and WC (-1.78 cm; 95% CI: -3.02 to -0.54), while increasing FFM (+2.32 kg; 95% CI: +0.49 to +4.14). Furthermore, leptin levels decreased significantly (-1.42 ng/mL; 95% CI: -2.35 to -0.49), whereas BMI, adiponectin, HC, and total body fat percentage showed no significant changes. Subgroup analyses revealed stronger effects in interventions lasting >8 weeks and in participants aged <50 years. No substantial publication bias was detected. Carotenoid supplementation exerts modest but favorable effects on body composition and leptin regulation, supporting its potential as an adjunct in metabolic health improvement. Longer, high-quality RCTs are warranted to confirm these findings and clarify dose-response relationships.</p>","PeriodicalId":19339,"journal":{"name":"Nutrition & Diabetes","volume":"16 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13737139/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149334735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yangguo Zhao, Xinrui Yang, Yang Bai, Dorothy Ngo Sheung Chan, Caixia Li
{"title":"Effectiveness of eHealth lifestyle interventions on management of metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis.","authors":"Yangguo Zhao, Xinrui Yang, Yang Bai, Dorothy Ngo Sheung Chan, Caixia Li","doi":"10.1038/s41387-026-00457-3","DOIUrl":"10.1038/s41387-026-00457-3","url":null,"abstract":"<p><p>eHealth lifestyle interventions have emerged as promising management strategies for metabolic dysfunction-associated steatotic liver disease (MASLD). Our review aimed to synthesize the most recent evidence to evaluate the effectiveness of eHealth lifestyle interventions on clinical and behavioral outcomes in adults with MASLD. Twelve databases (Medline, Web of Science Core Collection, Embase, Cochrane Central Register of Controlled Trials, ProQuest Health & Medical Collection, CINAHL Complete, Academic Search Complete, Scopus, Emerald, China National Knowledge Infrastructure, Wanfang Data, and VIP Database) were searched from inception to April 2, 2025. Thirteen randomized controlled trials and fifteen quasi-experimental trials comprising 2579 adult patients with MASLD were included. Seven intervention components were identified: goal setting, health education, consultation, self- and device-monitoring, feedback, patient reminders, and social support. Meta-analysis of randomized controlled trials demonstrated that eHealth lifestyle interventions were significantly superior to standard care in reducing weight, body mass index, waist circumference, alanine aminotransferase, aspartate aminotransferase, and γ-glutamyl transferase levels, and improving MASLD status. Improvements in self-management, dietary adherence, physical activity, exercise, and quality of life were also observed. Our findings suggest that ehealth intervention is a better choice for the patients with MASLD to achieve precise and scalable management. PROSPERO CRD420251001470. TRIAL REGISTRATION: PROSPERO CRD420251001470; https://www.crd.york.ac.uk/PROSPERO/view/CRD420251001470 .</p>","PeriodicalId":19339,"journal":{"name":"Nutrition & Diabetes","volume":"16 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13677714/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149220377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Association of an almond-based low-carbohydrate diet with continuous glucose monitoring metrics in patients with type 2 diabetes mellitus: a randomized controlled trial.","authors":"Xianming Li, Yanqin Xu, Xulin Wang, Yu Ding, Sihui Luo, Yu Gao","doi":"10.1038/s41387-026-00456-4","DOIUrl":"10.1038/s41387-026-00456-4","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the association between an almond-based low-carbohydrate diet (LCD) and continuous glucose monitoring (CGM) metrics in patients with type 2 diabetes mellitus (T2DM).</p><p><strong>Methods: </strong>This was a prospective randomized controlled study. Hospitalized patients with T2DM from Changshu No.1 People's Hospital were recruited from January 2022 to December 2022. 33 patients using CGM were included and randomly divided into the low-fat diet (LFD) group or the LCD with almonds group based on the random number table. Primary CGM metrics including time in range (TIR), time in tight range (TITR), time above range (TAR), time below range (TBR) were compared between the two groups. Linear regression analysis was performed to assess the association between diet group and nocturnal glycemic metrics.</p><p><strong>Results: </strong>Compared to LFD group, patients in the LCD with almonds group had higher nighttime TIR [98.51% (95.83, 99.88) vs. 91.67% (89.52, 98.07), P < 0.01] and TITR [94.14% (87.57, 98.41) vs. 77.58% (52.18, 90.58), P < 0.05]. Nighttime TAR [0.00% (0.00, 0.00) vs. 1.39% (0.00, 7.95), P < 0.01], HBGI [0.15 (0.01, 0.34) vs. 0.98 (0.08, 3.73), P < 0.05], and SD (15.57 ± 6.21 mg/dL vs. 23.62 ± 9.12 mg/dL, P < 0.05) were significantly lower in the LCD with almonds group. Multivariable regression demonstrated that LCD with almonds was independently associated with improvements in nocturnal TIR (β = 6.65%, P = 0.010) and TITR (β = 14.60%, P = 0.016) after adjustment for age, sex, and diabetes duration.</p><p><strong>Conclusion: </strong>The almond-based low-carbohydrate diet improved nocturnal glycemic control in patients with type 2 diabetes. These improvements in nocturnal TIR and TITR remained significant after multivariable adjustment for age, sex, and diabetes duration.</p><p><strong>Clinical trial registry: </strong>The study was registered at clinicaltrials.gov (registration no. ChiCTR2600116495).</p>","PeriodicalId":19339,"journal":{"name":"Nutrition & Diabetes","volume":"16 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13677719/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149220359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Weitao Su, Yayuan Mei, Ming Yang, Jingtao Wu, Ang Li
{"title":"Oral microbiota mediates the association of healthy dietary patterns with lower risk of advanced cardiovascular-kidney-metabolic syndrome.","authors":"Weitao Su, Yayuan Mei, Ming Yang, Jingtao Wu, Ang Li","doi":"10.1038/s41387-026-00455-5","DOIUrl":"10.1038/s41387-026-00455-5","url":null,"abstract":"<p><strong>Objectives: </strong>Existing evidence links diet and the oral microbiota to individual cardiovascular, kidney, and metabolic conditions, but these relationships have not been extended to the progressive stages of cardiovascular-kidney-metabolic (CKM) syndrome. We therefore investigated the associations among dietary patterns, the oral microbiome, and CKM stages.</p><p><strong>Methods: </strong>This cross-sectional study included 2051 representative US adults. Oral microbiota was characterized via 16S rRNA gene sequencing of oral rinse samples. Dietary patterns were assessed using multiple dietary indexes derived from 24-h dietary recalls. CKM stages were defined according to American Heart Association criteria. MaAsLin3 analysis and ordinal logistic regression were used to evaluate the associations of dietary indexes and oral microbiota with CKM stages. Mediation analysis was used to assess the mediating role of oral microbiota in the associations between various dietary indexes and CKM stages.</p><p><strong>Results: </strong>As CKM stages advanced, the oral microbial community tended to exhibit gradient shifts, primarily characterized by a potentially progressive reduction in the relative abundance of Pseudomonadota. Neisseria and Lautropia within Pseudomonadota, together with Gemella and Bergeyella, were negatively associated with CKM stages, whereas Lactobacillus was positively associated. Pseudomonadota-dominated salivatypes were associated with the lowest risk of advanced CKM stages. Higher healthy dietary indexes were associated with lower likelihood of advanced CKM stages and with higher abundance of Pseudomonadota taxa, particularly Neisseria. Notably, Neisseria and its higher taxonomies predominantly mediated the associations between dietary indexes and CKM stages.</p><p><strong>Conclusion: </strong>This study suggests that Neisseria-related taxa are predominant mediators linking dietary patterns to CKM stages. Modulation of the diet-microbiome axis may represent a complementary strategy for promoting health and potentially influencing CKM-associated outcomes, but our cross-sectional data should not be interpreted as establishing a causal protective role.</p>","PeriodicalId":19339,"journal":{"name":"Nutrition & Diabetes","volume":" ","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13669342/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148536458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Antonio Paoli, Giuseppe Cerullo, Samuele Paoli, Davide Charrier, Jacopo Givralli, Antonino Bianco, Giovanna Boccuzzo, Pietro Belloni, Lorenzo Cenci, Tatiana Moro
{"title":"Defining a ketone threshold for weight loss: evidence from 14 day daily β-hydroxybutyrate monitoring in 217 subjects on a ketogenic diet.","authors":"Antonio Paoli, Giuseppe Cerullo, Samuele Paoli, Davide Charrier, Jacopo Givralli, Antonino Bianco, Giovanna Boccuzzo, Pietro Belloni, Lorenzo Cenci, Tatiana Moro","doi":"10.1038/s41387-026-00454-6","DOIUrl":"10.1038/s41387-026-00454-6","url":null,"abstract":"<p><strong>Background: </strong>The ketogenic diet (KD) is a widely used nutritional intervention for weight loss. The beneficial effects of the KD are intrinsically linked to the state of physiological ketosis, where ketone bodies (KBs) raise, even though minimal effective threshold of blood ketone concentration that correlates with significant weight loss remains unclear. Therefore, the main purpose of this study was to identify the optimal β-hydroxybutyrate (βHB) threshold associated with weight loss in individuals with overweight or obesity undergoing a KD.</p><p><strong>Methods: </strong>This secondary analysis included 217 participants (111 males and 106 females) with overweight or obesity, who followed a KD for 14 days. Time to Ketosis (TtK)-defined as the number of days needed to reach and maintain a given ketone concentration-was calculated for each threshold.</p><p><strong>Results: </strong>Regression analysis showed that a βHB concentration of ≥0.5 mmol/L was the most associated with significant weight loss. Moreover, body weight and gender significantly influenced TtK, suggesting interindividual variability in achieving effective ketosis.</p><p><strong>Conclusions: </strong>Achieving and maintaining a ketonemia of at least 0.5 mmol/L may represent a clinically meaningful threshold to optimize weight loss in individuals undergoing a KD. Monitoring βHB levels and reducing TtK may improve individual responsiveness to KD-based interventions.</p>","PeriodicalId":19339,"journal":{"name":"Nutrition & Diabetes","volume":" ","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13645730/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148448388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Xin Wen, Jin Mei, Yidan Jiang, Meiyu Qian, Juan Wang, Shibo Xu, Yurui Su, Lili Xu, Qin Liu, Mengyuan Zhao, Huizi Zhang, Jingzhou Wang, Cuizhe Wang, Jun Zhang
{"title":"GULP1 enhances GLUT4 translocation by counteracting ACAP1-ARF6 inhibition.","authors":"Xin Wen, Jin Mei, Yidan Jiang, Meiyu Qian, Juan Wang, Shibo Xu, Yurui Su, Lili Xu, Qin Liu, Mengyuan Zhao, Huizi Zhang, Jingzhou Wang, Cuizhe Wang, Jun Zhang","doi":"10.1038/s41387-026-00452-8","DOIUrl":"10.1038/s41387-026-00452-8","url":null,"abstract":"<p><strong>Objectives: </strong>The molecular underpinnings of obesity-induced insulin resistance, a key driver of type 2 diabetes mellitus (T2DM), remain incompletely understood, limiting targeted therapies. While our prior work revealed that miR‑548ab impairs glucose homeostasis by downregulating GULP1, the precise mechanism by which GULP1 regulates insulin sensitivity, particularly through the GLUT4 trafficking machinery, is unknown. This study aimed to elucidate the novel function and molecular basis of GULP1 in controlling insulin-stimulated GLUT4 translocation and systemic glucose metabolism.</p><p><strong>Methods: </strong>Bioinformatics analysis predicted interactions between GULP1 and GLUT4 vesicle regulators (ACAP1, ARF6). In vitro and in vivo models were used to assess GULP1's effects on glucose uptake and GLUT4 translocation. Insulin resistance was evaluated via glucose tolerance tests and insulin sensitivity assays. Mechanistic studies investigated how GULP1 promotes insulin-mediated GLUT4 translocation to the plasma membrane by alleviating ACAP1-induced inhibition of ARF6 activity.</p><p><strong>Results: </strong>GULP1 significantly enhanced glucose uptake in adipocytes and muscle cells by promoting GLUT4 translocation to the plasma membrane. In obese mice, GULP1 overexpression improved insulin sensitivity and glucose tolerance. Mechanistically, GULP1 counteracted ACAP1's inhibition of ARF6 activity, thereby facilitating insulin-stimulated GLUT4 trafficking.</p><p><strong>Conclusion: </strong>GULP1 can bind to ACAP1 and ARF6, and alleviate the inhibitory effect of ACAP1 on ARF6 activity, thereby enhancing insulin-mediated glucose uptake and improving insulin sensitivity in obese mice. This study reveals a novel mechanism of GULP1 in glucose metabolism and provides a new therapeutic target for treating obesity-related metabolic diseases.</p>","PeriodicalId":19339,"journal":{"name":"Nutrition & Diabetes","volume":" ","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13642948/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148423087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}